Oliver Zolk

11PUBLICATIONS
58CO-AUTHORS
Toxicology (incl. clinical toxicology)Liquid biopsiesPharmacogenomicsMedicine, nursing and health curriculum and pedagogyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 16, 2025
Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database.

Tabea Ramin, Jens-Uwe Peter, Michael Schneider

|Sep 28, 2024
From 2D to 3D In Vitro World: Sonodynamically-Induced Prooxidant Proapoptotic Effects of C60-Berberine Nanocomplex on Cancer Cells.

Aleksandar Radivoievych, Sophia Schnepel, Svitlana Prylutska

|Apr 27, 2024
Pharmacokinetics, Pharmacodynamics, and Side Effects of Midazolam: A Review and Case Example.

Jens-Uwe Peter, Peter Dieudonné, Oliver Zolk

|Mar 18, 2022
COVID-19 pandemic-related adaptations of medical education in clinical pharmacology - impact on students and lecturers at a German university.

Susanne Hafner, Oliver Zolk, Holger Barth

|Feb 17, 2022
Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study.

Oliver Zolk, Annika von dem Knesebeck, Norbert Graf

|Dec 15, 2021
Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study.

Oliver Zolk, Timo Greiner, Michael Schneider

Pageof 2

Frequent Collaborators

3 joint publications

André G Uitterlinden

3 joint publications

Marry M van den Heuvel-Eibrink

2 joint publications

Annelot Jm Meijer

2 joint publications

Linda Broer